Volpara Health Technologies Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 31.48 | -100% | -13.84 | -100% |
| P/S |
|
5.57 | 3.24 | 71.83% |
|
|
| P/BV |
|
3.8 | 3.36 | 13.16% |
|
|
| P/FCF |
|
0 | 21.26 | -100% |
|
|
| Ev/Ebitda |
|
-33.39 | 9.95 | -435.42% |
|
|
| Ev/S |
|
5.26 | 1.89 | 178.04% |
|
|
| Ev/FCF |
|
-29.18 | 19.96 | -246.2% |
|
|
| E/P |
|
0 | 1.47 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-15.76 | 24.35 | -164.74% | -99.12 | -84.1% |
| ROE |
|
-19.12 | 13.19 | -244.98% |
|
|
| ROA |
|
-12.37 | 6.14 | -301.6% |
|
|
| ROIC |
|
0 | 15.56 | -100% |
|
|
| ROS |
|
-27.99 | 12.56 | -322.86% |
|
|
| ROCE |
|
-21.46 | 14.36 | -249.5% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.3769 | 6.21 | -106.07% | -0.3075 | +22.59% |
| Nеt Debt/Ebitda |
|
1.93 | -5.72 | -133.65% |
|
|
| Debt/Ratio |
|
0.0263 | 0.2122 | -87.62% |
|
|
| Debt/Equity |
|
0.8113 | 12.49 | -93.51% |
|
|
| Debt/Net Income |
|
-0.2122 | 15.05 | -101.41% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.76 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.21 | -100% | ||
| DSI |
|
0 | 0.7783 | -100% |
|
|
| Average dividend growth |
|
0 | -269.81 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 2.8 | -100% |
|
|
| Average percentage for payments |
|
0 | 246.79 | -100% |
|
|
| Difference from average difference in sector |
|
-1.76 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
497.84 | 140.59 | 254.11% | ||
| Growth impulse Ebitda in 5 years |
|
-52.62 | 107.17 | -149.1% | ||
| Growth impulse Net Income in 5 years |
|
-18.41 | 123.16 | -114.95% | ||
| Growth impulse FCF in 5 years |
|
-44.24 | 93.68 | -147.22% | ||
| Growth impulse EPS in 5 years |
|
-24.53 | 229.02 | -110.71% |
IP Score
2.89/10
